These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro culture of clonogenic leukaemic cells in acute myeloid leukaemia: growth pattern and drug sensitivity. Marie JP, Zittoun R, Thevenin D, Mathieu M, Viguie F. Br J Haematol; 1983 Nov; 55(3):427-37. PubMed ID: 6580036 [Abstract] [Full Text] [Related]
4. Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells. Van Der Lely N, De Witte T, Muus P, Raymakers R, Preijers F, Haanen C. Exp Hematol; 1991 May; 19(4):267-72. PubMed ID: 2055291 [Abstract] [Full Text] [Related]
5. The effects of exposure to cytosine arabinoside upon the proliferation of leukemia colony forming units in vitro. Preisler HD. Med Pediatr Oncol; 1982 May; 10 Suppl 1():149-55. PubMed ID: 7162460 [Abstract] [Full Text] [Related]
7. In vitro evidence for dose-dependent cytotoxicity as the predominant effect of low dose Ara-C on human leukemic and normal marrow cells. Chan CS, Schechter GP. Cancer Chemother Pharmacol; 1989 May; 23(2):87-94. PubMed ID: 2910516 [Abstract] [Full Text] [Related]
8. A comparison of two methods for determining the sensitivity of human myeloid colony-forming units to cytosine arabinoside. Preisler HD, Epstein J. Br J Haematol; 1981 Apr; 47(4):519-27. PubMed ID: 7213575 [Abstract] [Full Text] [Related]
9. Comparative effects of busulfan, cytosine arabinoside and adriamycin on different maturation stages of normal human bone marrow cells. Tohda S, Nagata K, Suzuki T, Nara N. Acta Haematol; 1990 Apr; 83(1):16-21. PubMed ID: 2105564 [Abstract] [Full Text] [Related]
10. Effects of chemotherapy on bone marrow stroma in mice with acute myelogenous leukemia. Correlation with CFU-C and CFU-D. Ben-Ishay Z, Prindull G, Sharon S, Borenstein A. Leuk Res; 1985 Apr; 9(8):1059-67. PubMed ID: 3862923 [Abstract] [Full Text] [Related]
13. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture. Grant S, Bhalla K, Arlin Z, Howe CW. Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268 [Abstract] [Full Text] [Related]
15. Recombinant GM-CSF modulates the metabolism of cytosine arabinoside in leukemic cells in bone marrow. Tanaka M. Leuk Res; 1993 Jul; 17(7):585-92. PubMed ID: 8326741 [Abstract] [Full Text] [Related]
17. Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity. Bhalla K, MacLaughlin W, Cole J, Arlin Z, Baker M, Graham G, Grant S. Blood; 1987 Aug; 70(2):568-71. PubMed ID: 3607288 [Abstract] [Full Text] [Related]
18. Different sensitivity of normal and leukaemic progenitor cells to Ara-C and IL-3 combined treatment. Lista P, Brizzi MF, Rossi M, Resegotti L, Clark SC, Pegoraro L. Br J Haematol; 1990 Sep; 76(1):21-6. PubMed ID: 2223644 [Abstract] [Full Text] [Related]
19. Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells. Grant S, Traylor R, Bhalla K, McCrady C, Pettit GR. Leukemia; 1992 May; 6(5):432-9. PubMed ID: 1593908 [Abstract] [Full Text] [Related]
20. Bone marrow stromal deficiency in acute myeloid leukemia in mice. Ben-Ishay Z, Prindull G, Borenstein A, Sharon S. Leuk Res; 1984 May; 8(6):1057-64. PubMed ID: 6595479 [Abstract] [Full Text] [Related] Page: [Next] [New Search]